Philip G. Tibbo - Publications

Affiliations: 
Psychiatry University of Alberta, Edmonton, Alberta, Canada 
Area:
Physiological Psychology, Neurobiology Biology, Mental Health

65 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 N Bissonnette J, Anderson TJ, McKearney KJ, Tibbo PG, Fisher DJ. Alteration of Resting Electroencephalography by Acute Caffeine Consumption in Early Phase Psychosis. Clinical Eeg and Neuroscience. 15500594211057355. PMID 34806929 DOI: 10.1177/15500594211057355  1
2021 McKee KA, Hmidan A, Crocker CE, Lam RW, Meyer JH, Crockford D, Trépanier A, Aitchison KJ, Tibbo PG. Potential therapeutic benefits of cannabinoid products in adult psychiatric disorders: A systematic review and meta-analysis of randomised controlled trials. Journal of Psychiatric Research. 140: 267-281. PMID 34119912 DOI: 10.1016/j.jpsychires.2021.05.044  1
2021 Bahji A, Meyyappan AC, Hawken ER, Tibbo PG. Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. The International Journal On Drug Policy. 97: 103295. PMID 34062288 DOI: 10.1016/j.drugpo.2021.103295  0.01
2021 Merritt K, McGuire PK, Egerton A, Aleman A, Block W, Bloemen OJN, Borgan F, Bustillo JR, Capizzano AA, Coughlin JM, De la Fuente-Sandoval C, Demjaha A, Dempster K, Do KQ, ... ... Tibbo PG, et al. Association of Age, Antipsychotic Medication, and Symptom Severity in Schizophrenia With Proton Magnetic Resonance Spectroscopy Brain Glutamate Level: A Mega-analysis of Individual Participant-Level Data. Jama Psychiatry. PMID 33881460 DOI: 10.1001/jamapsychiatry.2021.0380  1
2021 Crocker CE, Carter AJE, Emsley JG, Magee K, Atkinson P, Tibbo PG. When Cannabis Use Goes Wrong: Mental Health Side Effects of Cannabis Use That Present to Emergency Services. Frontiers in Psychiatry. 12: 640222. PMID 33658953 DOI: 10.3389/fpsyt.2021.640222  0.01
2021 Joyce KM, Thompson K, Good KP, Tibbo PG, O'Leary ME, Perrot TS, Hudson A, Stewart SH. The Impact of Depressed Mood and Coping Motives on Cannabis Use Quantity across the Menstrual Cycle in those with and without Pre-Menstrual Dysphoric Disorder. Addiction (Abingdon, England). PMID 33651443 DOI: 10.1111/add.15465  1
2020 Tibbo PG, McKee KA, Meyer JH, Crocker CE, Aitchison KJ, Lam RW, Crockford DN. Are There Therapeutic Benefits of Cannabinoid Products in Adult Mental Illness? Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720945525. PMID 32911977 DOI: 10.1177/0706743720945525  1
2020 Cookey J, McGavin J, Crocker CE, Matheson K, Stewart SH, Tibbo PG. A Retrospective Study of the Clinical Characteristics Associated with Alcohol and Cannabis use in Early Phase Psychosis. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 706743720905201. PMID 32013556 DOI: 10.1177/0706743720905201  1
2020 McCay E, Tibbo P, Conrad G, Crocker C, Langley J, Kirwan N, Aiello A, Danaher A, Sheasgreen C. Prepared for transition? A cross-sectional descriptive study of the gains attained in early psychosis programs. Early Intervention in Psychiatry. PMID 31943787 DOI: 10.1111/eip.12916  0.01
2020 Crocker C, Teehan M, Ursuliak Z, Morrison J, Robertson N, Alexiadis M, Tibbo P. S238. PATIENT ENGAGEMENT TO EARLY INTERVENTION IN PSYCHOSIS SERVICES: RETROSPECTIVE ANALYSIS OF ENGAGEMENT PATTERNS Schizophrenia Bulletin. 46: S129-S130. DOI: 10.1093/Schbul/Sbaa031.304  1
2020 Crocker C, Cox A, Abidi S, Ursuliak Z, Epstein N, Hughes J, Crown M, Tibbo P. M238. CREATION OF A PEER SUPPORT PROGRAM TO SUPPORT TRANSITIONS IN CARE FROM EARLY INTERVENTION SERVICES FOR PSYCHOSIS Schizophrenia Bulletin. 46: S226-S226. DOI: 10.1093/Schbul/Sbaa030.550  1
2019 Ursuliak Z, Hughes J, Crocker CE, MacKenzie A, Tibbo PG. Claymation art therapy in early phase psychosis: A qualitative study to explore participants' experiences with the program and identify outcome effects. Early Intervention in Psychiatry. PMID 31692270 DOI: 10.1111/Eip.12896  1
2019 Lodhi RJ, Wang Y, Macintyre G, Crocker C, Loverock A, Henriques BC, Heywood B, Sivapalan S, Bowker A, Majeau B, Bolt C, Bugbee D, Newton V, Tibbo P, Purdon SE, et al. Trend level gene-gender interaction effect for the BDNF rs6265 variant on age of onset of psychosis. Psychiatry Research. 280: 112500. PMID 31445421 DOI: 10.1016/J.Psychres.2019.112500  1
2019 Topyurek M, Tibbo P, Núñez C, Stephan-Otto C, Good K. Caffeine effects and schizophrenia: Is there a need for more research? Schizophrenia Research. PMID 31378556 DOI: 10.1016/J.Schres.2019.07.026  0.01
2019 Downing L, Kim DD, Procyshyn RM`, Tibbo P. Management of sexual adverse effects induced by atypical antipsychotic medication Journal of Psychiatry & Neuroscience : Jpn. 44: 287-288. PMID 31245972 DOI: 10.1503/Jpn.190053  0.01
2019 Fisher DJ, Rudolph ED, Ells EML, Knott VJ, Labelle A, Tibbo PG. Mismatch negativity-indexed auditory change detection of speech sounds in early and chronic schizophrenia. Psychiatry Research. Neuroimaging. 287: 1-9. PMID 30933744 DOI: 10.1016/j.pscychresns.2019.03.010  1
2019 Riel H, Lee JB, Fisher DJ, Tibbo PG. Sex differences in ERP waveforms of primary psychotic disorders: A systematic review. International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology. PMID 30790596 DOI: 10.1016/J.Ijpsycho.2019.02.006  1
2019 Topyurek M, Tibbo P, Fisk J, Good K. T104. The Association Among Caffeine Intake, Cognition, And Symptomatology In Schizophrenia Patients Schizophrenia Bulletin. 45. DOI: 10.1093/Schbul/Sbz019.384  0.01
2018 Crocker CE, Tibbo PG. Corrigendum: Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia. Frontiers in Pharmacology. 9: 1417. PMID 30555331 DOI: 10.3389/Fphar.2018.01417  0.01
2018 Cookey J, Crocker C, Bernier D, Newman A, Stewart S, McAllindon D, Tibbo P. Microstructural Findings In White Matter Associated With Cannabis And Alcohol Use In Early Phase Psychosis: A Diffusion Tensor Imaging (DTI) And Relaxometry Study. Brain Connectivity. PMID 30417651 DOI: 10.1089/Brain.2018.0611  1
2018 Crocker CE, Tibbo PG. Confused Connections? Targeting White Matter to Address Treatment Resistant Schizophrenia. Frontiers in Pharmacology. 9: 1172. PMID 30405407 DOI: 10.3389/Fphar.2018.01172  0.01
2018 Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, Ren H, Dimitrijevic A, Bugbee DA, Loverock A, Majeau B, Sivapalan S, Newton VM, Tibbo P, Purdon SE, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain and Behavior. 8: e01120. PMID 30264447 DOI: 10.1002/brb3.1120  1
2018 Luoma LM, Macintyre G, Tibbo PG, Wild TC, Colman I, Purdon SE. NPAS3 exonic SNP genotype is linked to working memory performance in healthy young adults. Psychiatry Research. 265: 263-264. PMID 29763846 DOI: 10.1016/J.Psychres.2018.04.063  1
2018 Ells EML, Rudolph ED, Sculthorpe-Petley L, Abriel SC, Campbell DJ, Tibbo PG, Fisher DJ. ALTERATIONS OF COMPLEX MISMATCH NEGATIVITY (cMMN) ELICITED BY A TWO-TONE PATTERN PARADIGM IN EARLY-PHASE PSYCHOSIS. Biological Psychology. PMID 29596955 DOI: 10.1016/J.Biopsycho.2018.03.010  1
2018 Fisher DJ, Campbell DJ, Abriel SC, Ells EML, Rudolph ED, Tibbo PG. Auditory Mismatch Negativity and P300a Elicited by the "Optimal" Multi-feature Paradigm in Early Schizophrenia. Clinical Eeg and Neuroscience. 1550059418761459. PMID 29502452 DOI: 10.1177/1550059418761459  1
2018 Lodhi R, Wang Y, McIntyre G, Rossolatos D, Sivapalan S, Henriques B, Heywood B, Crocker C, Purdon S, Aitchison K, Tibbo P. F190. EFFECT OF SELECTED GENE VARIANTS ON THE RELATIONSHIP BETWEEN EARLY CANNABIS USE AND AGE OF ONSET OF PSYCHOSIS Schizophrenia Bulletin. 44: S295-S295. DOI: 10.1093/Schbul/Sby017.721  1
2018 Cookey J, Crocker C, Bernier D, Newman A, Stewart S, McAllindon D, Tibbo P. F231. Microstructural Changes in White Matter Associated With Alcohol Use in Early Phase Psychosis: A Diffusion Tensor Imaging (DTI) and Relaxometry Study Biological Psychiatry. 83: S328-S329. DOI: 10.1016/J.Biopsych.2018.02.845  1
2017 Lodhi RJ, Wang Y, Rossolatos D, MacIntyre G, Bowker A, Crocker C, Ren H, Dimitrijevic A, Bugbee DA, Loverock A, Majeau B, Sivapalan S, Newton VM, Tibbo P, Purdon SE, et al. Investigation of the COMT Val158Met variant association with age of onset of psychosis, adjusting for cannabis use. Brain and Behavior. 7: e00850. PMID 29201551 DOI: 10.1002/Brb3.850  1
2017 McAllindon DP, Tibbo PG, Eskes GA. Is performance on probed serial recall tasks in schizophrenia related to duration of Attentional Blink? Schizophrenia Research. Cognition. 7: 8-12. PMID 28740823 DOI: 10.1016/J.Scog.2016.12.001  1
2017 Crocker CE, Purdon SE, Hanstock CC, Lakusta B, Seres P, Tibbo PG. Enduring changes in brain metabolites and executive functioning in abstinent cocaine users. Drug and Alcohol Dependence. 178: 435-442. PMID 28710968 DOI: 10.1016/J.Drugalcdep.2017.04.034  1
2017 Crocker CE, Tibbo PG. The interaction of gender and cannabis in early phase psychosis. Schizophrenia Research. PMID 28506705 DOI: 10.1016/J.Schres.2017.04.046  0.01
2016 Aydin C, Tibbo PG, Ursuliak Z. Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 61: 367-372. PMID 27254846 DOI: 10.1177/0706743716639931  1
2016 Bernier D, Bartha R, McAllindon D, Hanstock CC, Marchand Y, Dillen KN, Gallant M, Good KP, Tibbo PG. Illness versus substance use effects on the frontal white matter in early phase schizophrenia: A 4Tesla (1)H-MRS study. Schizophrenia Research. PMID 27161760 DOI: 10.1016/J.Schres.2016.04.022  1
2015 Gardner DM, Abidi S, Ursuliak Z, Morrison J, Teehan MD, Tibbo PG. Incidence of Oculogyric Crisis and Long-Term Outcomes With Second-Generation Antipsychotics in a First-Episode Psychosis Program. Journal of Clinical Psychopharmacology. 35: 715-8. PMID 26485339 DOI: 10.1097/Jcp.0000000000000411  1
2015 Rudolph ED, Ells EM, Campbell DJ, Abriel SC, Tibbo PG, Salisbury DF, Fisher DJ. Finding the missing-stimulus mismatch negativity (MMN) in early psychosis: Altered MMN to violations of an auditory gestalt. Schizophrenia Research. 166: 158-63. PMID 26072323 DOI: 10.1016/J.Schres.2015.05.028  1
2014 Crocker CE, Bernier DC, Hanstock CC, Lakusta B, Purdon SE, Seres P, Tibbo PG. Prefrontal glutamate levels differentiate early phase schizophrenia and methamphetamine addiction: a (1)H MRS study at 3Tesla. Schizophrenia Research. 157: 231-7. PMID 24906219 DOI: 10.1016/J.Schres.2014.05.004  1
2014 Cookey J, Bernier D, Tibbo PG. White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies. Schizophrenia Research. 156: 137-42. PMID 24842540 DOI: 10.1016/J.Schres.2014.04.026  1
2014 Bernier D, Macintyre G, Bartha R, Hanstock CC, McAllindon D, Cox D, Purdon S, Aitchison KJ, Rusak B, Tibbo PG. NPAS3 variants in schizophrenia: a neuroimaging study. Bmc Medical Genetics. 15: 37. PMID 24674381 DOI: 10.1186/1471-2350-15-37  1
2013 Bernier D, Cookey J, McAllindon D, Bartha R, Hanstock CC, Newman AJ, Stewart SH, Tibbo PG. Multimodal neuroimaging of frontal white matter microstructure in early phase schizophrenia: the impact of early adolescent cannabis use. Bmc Psychiatry. 13: 264. PMID 24131511 DOI: 10.1186/1471-244X-13-264  1
2013 Tibbo PG, Bernier D, Hanstock CC, Seres P, Lakusta B, Purdon SE. 3-T proton magnetic spectroscopy in unmedicated first episode psychosis: a focus on creatine. Magnetic Resonance in Medicine. 69: 613-20. PMID 22511463 DOI: 10.1002/Mrm.24291  1
2011 Tibbo P, Bernier D, Seres P, Hanstock C, Nguyen-Burns A, Purdon S. Investigation of 3T 1H-MRS and psychotic symptoms in unmedicated first episode psychosis International Clinical Psychopharmacology. 26. DOI: 10.1097/01.Yic.0000405840.79959.47  1
2010 Good KP, Tibbo P, Milliken H, Whitehorn D, Alexiadis M, Robertson N, Kopala LC. An investigation of a possible relationship between olfactory identification deficits at first episode and four-year outcomes in patients with psychosis Schizophrenia Research. 124: 60-65. PMID 20692126 DOI: 10.1016/J.Schres.2010.07.010  1
2010 Swainson J, Marsh M, Tibbo PG. Psychiatric residents as teachers: development and evaluation of a teaching manual. Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association For Academic Psychiatry. 34: 305-9. PMID 20576994 DOI: 10.1176/Appi.Ap.34.4.305  0.01
2010 Macintyre G, Alford T, Xiong L, Rouleau GA, Tibbo PG, Cox DW. Association of NPAS3 exonic variation with schizophrenia. Schizophrenia Research. 120: 143-9. PMID 20466522 DOI: 10.1016/J.Schres.2010.04.002  1
2010 McAllindon DP, Wilman AH, Purdon SE, Tibbo PG. Functional magnetic resonance imaging of choice reaction time in chronic schizophrenia and first-degree relatives. Schizophrenia Research. 120: 232-3. PMID 20153139 DOI: 10.1016/J.Schres.2010.01.015  1
2009 Lari H, Bullard M, Colman I, Melledo J-L, Tibbo P. P02-247 Do patients follow-up with discharge advice after psychiatric assessment and discharge from emergency department? European Psychiatry. 24: 1-1. DOI: 10.1016/S0924-9338(09)71170-8  0.01
2008 Batra NA, Seres-Mailo J, Hanstock C, Seres P, Khudabux J, Bellavance F, Baker G, Allen P, Tibbo P, Hui E, Le Melledo JM. Proton magnetic resonance spectroscopy measurement of brain glutamate levels in premenstrual dysphoric disorder. Biological Psychiatry. 63: 1178-84. PMID 18061146 DOI: 10.1016/J.Biopsych.2007.10.007  1
2008 Choi C, Bhardwaj PP, Seres P, Kalra S, Tibbo PG, Coupland NJ. Measurement of glycine in human brain by triple refocusing 1H-MRS in vivo at 3.0T. Magnetic Resonance in Medicine. 59: 59-64. PMID 18050319 DOI: 10.1002/Mrm.21450  1
2006 Grant SL, Shulman Y, Tibbo P, Hampson DR, Baker GB. Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 844: 278-82. PMID 16890503 DOI: 10.1016/J.Jchromb.2006.07.022  1
2006 Valiakalayil A, Hanstock C, Seres P, Purdon S, Tibbo P. 0096 Proton Mrs Investigation Of Glutamate Levels And Executive Functioning In First Episode Psychosis Schizophrenia Research. 86. DOI: 10.1016/S0920-9964(06)70206-7  1
2005 Shulman Y, Tibbo PG. Neuroactive steroids in schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 50: 695-702. PMID 16363462 DOI: 10.1177/070674370505001109  1
2004 Chue P, Tibbo P, Wright E, Van Ens J. Client and community services satisfaction with an assertive community treatment subprogram for inner-city clients in Edmonton, Alberta. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 621-4. PMID 15503734 DOI: 10.1177/070674370404900908  0.01
2004 Tibbo P, Templeman K. The RCPSC oral examination: patient perceptions and impact on participating psychiatric patients. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 49: 480-6. PMID 15362253 DOI: 10.1177/070674370404900710  0.01
2004 Valiakalayil A, Paulson LA, Tibbo P. Burden in adolescent children of parents with schizophrenia. The Edmonton High Risk Project. Social Psychiatry and Psychiatric Epidemiology. 39: 528-535. PMID 15243690 DOI: 10.1007/S00127-004-0778-9  1
2004 Tibbo P, Hanstock C, Valiakalayil A, Allen P. 3-T Proton MRS investigation of glutamate and glutamine in adolescents at high genetic risk for schizophrenia American Journal of Psychiatry. 161: 1116-1118. PMID 15169703 DOI: 10.1176/Appi.Ajp.161.6.1116  1
2003 Tibbo P, Allen P, Hanstock C, Valiakalayil A, Paulson L. Proton magnetic resonance spectroscopy (1H-MRS) in adolescents at risk for schizophrenia: The Edmonton high risk project Schizophrenia Research. 60: 246. DOI: 10.1016/S0920-9964(03)81261-6  1
2001 Tibbo P, Joffe K, Chue P, Metelitsa A, Wright E. Global assessment of functioning following assertive community treatment in Edmonton, Alberta: a longitudinal study. The Canadian Journal of Psychiatry. 46: 144-148. PMID 11280083 DOI: 10.1177/070674370104600205  0.01
2000 Prior TI, Chue PS, Tibbo P. Investigation of Turner syndrome in schizophrenia American Journal of Medical Genetics. 96: 373-378. PMID 10898917 DOI: 10.1002/1096-8628(20000612)96:3<373::Aid-Ajmg26>3.0.Co;2-Z  1
2000 Tibbo P, Chue P, Wright E, Metelitsa A, Joffe K. Longitudinal global assessment of functioning (GAF) following assertive community treatment (ACT) Schizophrenia Research. 41: 229. DOI: 10.1016/S0920-9964(00)90874-0  0.01
2000 Tibbo P, Nopoulos P, Allen P, Valiakalayil A. Home structure of adolescents at high-risk for schizophrenia Schizophrenia Research. 41: 173. DOI: 10.1016/S0920-9964(00)90720-5  1
2000 Li DM, Chokka P, McEwan AJB, Logus W, Mantei S, Hanson J, Tibbo P. 320. A SPECT study of gender and striatal dopamine Biological Psychiatry. 47. DOI: 10.1016/S0006-3223(00)00584-9  0.01
1999 Prior TI, Chue PS, Tibbo P, Baker GB. Drug metabolism and atypical antipsychotics European Neuropsychopharmacology. 9: 301-309. PMID 10422890 DOI: 10.1016/S0924-977X(98)00040-6  1
1998 Tibbo P, Nopoulos P, Arndt S, Andreasen NC. Corpus callosum shape and size in male patients with schizophrenia. Biological Psychiatry. 44: 405-12. PMID 9777169 DOI: 10.1016/S0006-3223(98)00096-1  0.01
1998 Tibbo P. Images in Psychiatry: Canada American Journal of Psychiatry. 155. DOI: 10.1176/Ajp.155.4.573A  0.01
1997 Tibbo P, Silverstone PH, McEwan AJ, Scott J, Joshua A, Goldberg K. Striatal dopamine D2 receptor binding with 123I-epidepride: an in vivo SPECT study Psychiatry Research-Neuroimaging. 68: 180. DOI: 10.1016/S0925-4927(97)81588-0  0.01
Show low-probability matches.